Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Dunlop

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Journal of Neurochemistry|June 30, 2006
WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native systemXavier Z Khawaja, Deborah L Smith, Stanley P Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptorAnnmarie L Sabb, Robert L Vogel, Gregory S Welmaker, et al.
The American Journal of Pathology|December 6, 2002
Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cellsJie Xu, Bo Jian, Richard Chu, et al.
Translational Neurodegeneration|March 16, 2017
Protein misfolding in neurodegenerative diseases: implications and strategiesPatrick Sweeney, Hyunsun Park, Marc Baumann, et al.
Brain Research|January 25, 2006
Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503Sharon Rosenzweig-Lipson, Jean Zhang, Hossein Mazandarani, et al.
Journal of Neurophysiology|March 30, 2007
Direct inhibition of Ih by analgesic loperamide in rat DRG neuronsDmitry V Vasilyev, Qin Shan, Yan Lee, et al.
The International Journal of Neuropsychopharmacology|June 22, 2012
Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's diseaseSylvia Navailles, Mélanie Lagière, Audrey Roumegous, et al.
European Journal of Pharmacology|July 13, 2010
Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine releaseH Beal McIlvain, Linh Ma, Brian Ludwig, et al.
Plos One|January 7, 2014
Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neuronsLi Li, Sashi Nadanaciva, Zdenek Berger, et al.
European Journal of Medicinal Chemistry|April 8, 2014
Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptorArianna Nencini, Cristiana Castaldo, Thomas A Comery, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Journal of Neurochemistry|June 30, 2006
WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native systemXavier Z Khawaja, Deborah L Smith, Stanley P Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptorAnnmarie L Sabb, Robert L Vogel, Gregory S Welmaker, et al.
The American Journal of Pathology|December 6, 2002
Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cellsJie Xu, Bo Jian, Richard Chu, et al.
Translational Neurodegeneration|March 16, 2017
Protein misfolding in neurodegenerative diseases: implications and strategiesPatrick Sweeney, Hyunsun Park, Marc Baumann, et al.
Brain Research|January 25, 2006
Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503Sharon Rosenzweig-Lipson, Jean Zhang, Hossein Mazandarani, et al.
Journal of Neurophysiology|March 30, 2007
Direct inhibition of Ih by analgesic loperamide in rat DRG neuronsDmitry V Vasilyev, Qin Shan, Yan Lee, et al.
The International Journal of Neuropsychopharmacology|June 22, 2012
Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's diseaseSylvia Navailles, Mélanie Lagière, Audrey Roumegous, et al.
European Journal of Pharmacology|July 13, 2010
Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine releaseH Beal McIlvain, Linh Ma, Brian Ludwig, et al.
Plos One|January 7, 2014
Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neuronsLi Li, Sashi Nadanaciva, Zdenek Berger, et al.
European Journal of Medicinal Chemistry|April 8, 2014
Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptorArianna Nencini, Cristiana Castaldo, Thomas A Comery, et al.
Pageof 10